Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
148 participants
OBSERVATIONAL
2000-01-31
2011-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Methods: Preterm infants born \<30 weeks' gestational age between 2000 and 2002 were prospectively included. aEEGs obtained within the first two weeks of life were evaluated and classified according to background activity, sleep-wake cycling (SWC) and seizure activity. Outcome was assessed at three years.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Early Development of Sleep-wake Cycles in Premature Infants and Its Impact on Neurodevelopmental Outcome
NCT01774318
Cerebral Function Monitoring in Premature Infants
NCT00873847
Theory of Mind in Preschool Children, School Children, Youths and Adults Born Preterm or Full-term
NCT02628015
Influence of Intrauterine Growth Restriction on Amplitude-integrated EEG in Preterm Infants
NCT01942525
Childhood Outcomes of Preterm Brain Abnormalities
NCT03410810
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* who had aEEGs in first 2 weeks of life
* who were assessed for outcome at 3 years of age
Exclusion Criteria
* had no aEEGs in first 2 weeks of life
* lost for follow-up at 3 years
24 Weeks
30 Weeks
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical University of Vienna
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Monika Olischar
Ass Prof Dr
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Monika Olischar, MD
Role: PRINCIPAL_INVESTIGATOR
Neonatology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medical University of Vienna
Vienna, , Austria
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
gender148
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.